Keywords: anika, reports, unfavorable, orthovisc, data, sec, investigation

Anika reports unfavorable Orthovisc data, SEC investigation

Article | 01 June 2000

Print This

Anika Therapeutics says that an initial analysis of data from a PhaseIII trial of Orthovisc (sodium hyaluronate), its treatment for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in